Patent · US Expired

Method and kit or detecting antibodies to antigens of Human Immunodeficiency Virus type 2 (HIV-2)

US5055391A · kind A · utility

26Cited by
1References
74Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 3, 1990
Grant dateOct 8, 1991
Priority date
Expiry dateJan 3, 2010

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S930/221
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to a new variety of retroviruses designated Human Immunodeficiency Virus Type II, HIV-II, samples of which have been deposited at CNCM as I-502 and I-532. It also concerns purified forms of the antigens which can be obtained from this virus, in particular from the gp 36 and gp 130-140 proteins. These various antigens are useful in medical diagnosis and kits, in particular by being placed in contact with serum of the patient to be diagnosed. Lastly, the invention relates to immunizing compositions, in particular containing at least one of glycoproteins gp 36 and gp 130-140.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.